Journal of Innovations in Applied Pharmaceutical Science (JIAPS)最新文献_第5页

A Pharmacological review on Cassia Auriculata 黑木香的药理研究进展

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-12-04 DOI: 10.37022/jiaps.v7i3.363

Hithesh Gowda H S, K. S, Shankar Jai, Umakanth B S, Syed sagheer Ahmed, R. M

引用次数: 1

Formulation and evaluation of microsphere of glipizide 格列吡嗪微球的制备及评价

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-11-29 DOI: 10.37022/jiaps.v7i3.362

V. V, Nagavani M

引用次数: 0

Molecular identification of chlorpyrifos and Malathion degrading bacteria 毒死蜱和马拉硫磷降解菌的分子鉴定

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-08-03 DOI: 10.37022/jiaps.v7i2.339

Sumanjali Avanigadda, Meena Vengalapati

{"title":"Molecular identification of chlorpyrifos and Malathion degrading bacteria","authors":"Sumanjali Avanigadda, Meena Vengalapati","doi":"10.37022/jiaps.v7i2.339","DOIUrl":"https://doi.org/10.37022/jiaps.v7i2.339","url":null,"abstract":"Fifteen strains of bacteria were successfully isolated from agriculture soil samples contains pesticides and from soil moisture around them. The isolates were capable of utilizing chlorpyrifos (Cp) and malathion as the sole source of carbon, phosphorus and energy. High yielding isolate KSCM-08 was identified based on16SrRNA sequencing. Genomic DNA was successfully extracted from bacterial isolate KSCM-08, and the total DNA content was determined to be 734±23 µg/gm. The absorbance ratio of extracted DNA at A260/280 has been found to be 1.96±0.2. 1381 nucleotide sequence of the PCR amplified 16s rRNA gene from bacterial isolate KSCM-08. The 16s rRNA gene sequence comprises 344 bp of adenine (A), 280 bp of thymine (T), 430 bp of guanine (G), and 327 bp of cytosine (C). The G+C percentage was determined to be 54.8%. The BLAST report demonstrates the similar sequences with the KSCM-08 16s rRNA sequence, along with their percentage of identity. The BLASTn analysis of the 1381 bp length 16s rRNA gene sequence of KSCM-08 against the GenBank database revealed that KSCM-08 exhibits similarity with Bacillus species. The evolutionary divergence of bacterial isolate KSCM-08 with its relative members was determined. A satisfactory result was established by the use of the 16S rRNA gene as a marker to evaluate the phylogenetic relationship and the bacteria was confirmed as Bacillus safensis.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130058303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A study on pharmacovigilance case processing 药物警戒病例处理的研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-08-02 DOI: 10.37022/jiaps.v7i2.338

Anil Kumar Y, Divya A, Sayamma B, Karishma Sk, R. Konda, Santhosh Kumar Ch

引用次数: 0

Assessment of quality of life in covid-19 patients post recovery- an observational analytical study covid-19患者康复后生活质量评估——一项观察性分析研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-06-29 DOI: 10.37022/jiaps.v7i2.332

Sai Padmini G, Sumathya P, Ratna Jyothirmai M, Niharika B, Gunasekhar S, T. B

引用次数: 0

Evaluation of quality of life (QOL), depression prevalence and distress in diabetes mellitus diagnosed patients of a tertiary care teaching hospital - a prospective interventional analytical study 三级护理教学医院糖尿病患者生活质量、抑郁患病率及苦恼程度的前瞻性介入分析研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-06-29 DOI: 10.37022/jiaps.v7i2.331

Sanjuna A, K.S.Vasanthasena D, N. M, Akhila P, Hemanthanissi B, U. V, Madhu Chandaka

{"title":"Evaluation of quality of life (QOL), depression prevalence and distress in diabetes mellitus diagnosed patients of a tertiary care teaching hospital - a prospective interventional analytical study","authors":"Sanjuna A, K.S.Vasanthasena D, N. M, Akhila P, Hemanthanissi B, U. V, Madhu Chandaka","doi":"10.37022/jiaps.v7i2.331","DOIUrl":"https://doi.org/10.37022/jiaps.v7i2.331","url":null,"abstract":"Diabetic Mellitus is a group of metabolic disorders characterized by hyperglycaemia, which occurs due to defects in insulin secretion, insulin action, or both. Diabetics distress is an emotional distress response characterized by extreme apprehension, discomfort, or dejection due to a perceived inability to cope with the challenges and demands of living with diabetes. The goals of clinical pharmacist is to management of about medication adherence, to evaluate the quality of life, identify depression levels among diabetic patients, to identify anxiety levels in diabetic patients, to evaluate diabetic distress and its effects among diabetics. Diabetic distress is the major problem associated with diabetics which is making patients losing their self-confidence and positive attitude towards life. Due to diabetic distress, depression and anxiety significant percentage of patients work exhibited poor quality of life. Proper counselling, continuous interaction, effective therapy by the clinical pharmacists could improve patients quality of life, diabetes causative and medication adherence.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126502097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Identifying the most commonly occurred clinical symptoms of covid-19 patients at southern hospitals and community setting – a retrospective study 确定南方医院和社区环境中covid-19患者最常见的临床症状——一项回顾性研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-06-28 DOI: 10.37022/jiaps.v7i2.333

S. Ch, Sreevani K, Tanish B, Madhu Chandaka, T. B

{"title":"Identifying the most commonly occurred clinical symptoms of covid-19 patients at southern hospitals and community setting – a retrospective study","authors":"S. Ch, Sreevani K, Tanish B, Madhu Chandaka, T. B","doi":"10.37022/jiaps.v7i2.333","DOIUrl":"https://doi.org/10.37022/jiaps.v7i2.333","url":null,"abstract":"Background: The First Case Of A Novel Coronavirus (COVID-19) Infection Was Detected In Wuhan, Fever And Respiratory Symptoms Have Been Frequently Reported In Patients Infected With This Virus. \u0000Aim: It Was Aimed To Detect The Most Commonly Occurred Clinical Symptoms Of COVID19 In Hospitals And Community Settings. \u0000Method: Patients Presenting To Southern Hospitals And Community Settings For COVID-19 Infection Were Included In The Study. Assessment Of Demographics And Background Information Of Covid-19 Infection Is Done And Next The Patients Were Questioned For 22 Symptoms And The Results Were Compared. Listing Out The Symptoms And Symptoms Status And Functionality Status Prior to The Collection Of All Data For Statistical Analysis To Represent The Results. \u0000Results: A Total Of 403 Patients With COVID-19 Positive Status Were Included In The Study. The Most Common Symptoms In The COVID-19 Positive Group Were: Cough (81.9%), Shortness Of Breath (78.7%), Sneezing (77.4%), Fever (91.4%), Headache (89.6%), Loss Of Taste (69.2%), And Muscle Pain (80.1%). \u0000Conclusion: Our Study Showed That Taste And Cough Were Important Markers In COVID-19 Infection.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"107 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124811890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chronic kidney disease and its complete scenario, management of chronic kidney disease by clinical pharmacists - a prospective interventional study 慢性肾脏疾病及其完整情况，临床药师对慢性肾脏疾病的管理-一项前瞻性介入研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-06-26 DOI: 10.37022/jiaps.v7i2.328

Padma Priya D, Jagadeeshwari K, Prema Kumari N, Abhisekhar M, U. V

{"title":"Chronic kidney disease and its complete scenario, management of chronic kidney disease by clinical pharmacists - a prospective interventional study","authors":"Padma Priya D, Jagadeeshwari K, Prema Kumari N, Abhisekhar M, U. V","doi":"10.37022/jiaps.v7i2.328","DOIUrl":"https://doi.org/10.37022/jiaps.v7i2.328","url":null,"abstract":"Chronic kidney disease is a growing epidemic worldwide. Nearly two-thirds of CKD patients have diabetes mellitus, hypertension, and both comorbid conditions. Several disease management programs are developed and they implement with help of physicians, and highly trained clinical pharmacists to improve disease management and improve clinical outcomes. The goals of clinical pharmacist in the management of CKD patients by focusing on Four key areas: To obtain information about medication non-adherence, To assess the patient complications for dialysis, to assess the prevalence of chronic kidney disease patients, To evaluate the clinical pharmacist’s role in improving patient medication adherence, To identify the correlation between CKD and other comorbidities, To observe the drug interactions in prescribed drugs. Lack of patient knowledge on CKD disease conditions, and limited reimbursement, lack of primary care by physicians and health care professionals are all barriers that must be overcome with help of the clinical pharmacist role in the management of CKD.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117024751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Quantum dots and its advancement in the treatment of Parkinson’s disease: a review 量子点及其在帕金森病治疗中的进展综述

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-04-28 DOI: 10.37022/jiaps.v7i1.316

Rupesh kumar Mani, C. K, Bharathi D R, Syed sagheer Ahmed, Gurusidda

引用次数: 1

Pharmacovigilance among patients with multi drug resistance tuberculosis (MDR-TB) treatment-a prospective study 耐多药结核病(MDR-TB)治疗患者的药物警戒——一项前瞻性研究

Journal of Innovations in Applied Pharmaceutical Science (JIAPS) Pub Date : 2022-04-26 DOI: 10.37022/jiaps.v7i1.308

A. D, R. C., P. K, V. V, N. P, V. P

{"title":"Pharmacovigilance among patients with multi drug resistance tuberculosis (MDR-TB) treatment-a prospective study","authors":"A. D, R. C., P. K, V. V, N. P, V. P","doi":"10.37022/jiaps.v7i1.308","DOIUrl":"https://doi.org/10.37022/jiaps.v7i1.308","url":null,"abstract":"Background: ADRs are frequent in patients of MDR-TB on DOTs-Plus drug regimen. Current study was carried out in tertiary care hospital. Recognition of types and frequency of adverse drug reactions in Intensive and continuation phase of MDR- TB Patients. \u0000Methods: It was a prospective observational study conducted in Damien Foundation Urban Leprosy & TB Centre, Nellore. All the MDR-TB patients admitted at the directly observed treatment, short course plus (DOTS plus) Center were enrolled and were monitored for ADRs. The causality and severity of the reactions were determined using Naranjo algorithm. \u0000Results: A total of 200 tuberculosis patients of MDR-TB on DOTS therapy were enrolled for the study. Out of 200 patients, 10 were dropouts, 10 defaulted so 190 patients assessed for ADRs, 129 patients developed 109 (56.48%) adverse drug reactions. The higher numbers of ADRs were observed in age group 31- 40yrs followed by 21-30yrs which were more common in men. Majority of adverse drug reactions were Gastrointestinal (GI) problems 48 (37.20%), followed by Ototoxicity 7 (5.42%) and Psychiatric Manifestations 3 (2.321 %) and skin problems 3 (2.32%). On evaluation of the causality of ADRs, majority were found to be Possible (57.95%). The severity assessment showed that most of the patients ADRs were of moderate level (42.04%). \u0000Conclusions: ADRs are major factor limiting completion of drug therapy under RNTCP and occurrence of drug resistance which requires attention of all health care professionals.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126218772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0